Diamyd Medical, a Swedish diabetes company focusing on the development of pharmaceuticals for the treatment of autoimmun…
Research
Diabetes UK to Fund New Diabetes Research
Diabetes UK announced that it would be dedicating almost £750,000 ($1,200,000) to four new research projects looking to …
First Human Embryonic Stem Cell Lines Approved for Use Under New NIH Guidelines
The National Institute of Health (NIH) announced the approval of the first 13 human embryonic stem cell (hESC) lines for…
Old Drug May Hold New Hope
A drug commonly used to treat non-Hodgkin's lymphoma and rheumatoid arthritis now also shows some promise in helping pat…
Success Rate of Islet Cells Transplants May Improve With New Treatment
TikoMed AB, a Swedish biotechnology company focused on development and commercialization of innovative treatments for im…
Interview With Dr. George Eisenbarth
We can prevent diabetes in animal models and we are trying to figure out how to prevent it in man...…
Interview with Kevan Herold: Doctor, Researcher, and Diabetic
I, like everyone else with diabetes, can find it tiring to never get a break from it...…
Spherix Inc. Announces Positive Results for Type 2 Therapy
Spherix Inc., an innovator in biotechnology for diabetes therapy, and a provider of technical and regulatory consulting …
Insulin Production Mechanism Discovered Which May Lead To Better Treatment of Diabetes
Researchers at the Hebrew University in Jerusalem, in collaboration with Japanese and American researchers, have discove…
Diabetes Genetic Marker Discovered
Compugen Ltd. announced today the discovery and experimental confirmation of a genetic marker for type 2 diabetes. A pr…
